Approval · Notice of Compliance 14641 · 2013
JETREA: Notice of Compliance 14641
Issued August 13, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14641
- Date
- August 13, 2013
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Ophthalomological
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JETREA | 02410818 | Cancelled Post Market |
Medicinal ingredients
- OCRIPLASMIN 2.5 MG per ML